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Recent advances in assisted reproductive technology
(ART), coupled with the emerging understanding in
molecular mechanisms of disorders of sex development
(DSD) and that of associated genetic infertility, have
given hopes for fertility in groups of patients who till
recently were denied biological parenthood.
Heterologous fertility potentiation, in the cytogenetic
infertility by donor oocytes, has been successfully used
by us and others. However, homologous fertility preser-
vation for this group of patients is evolving. Cryopreser-
vation of either the mature oocytes following ovarian
stimulation in post -pubertal Turner Syndrome (TS)
girls or that of ovarian tissue in prepubertal TS patients
are to be applied before actual ovarian failure occurs.
Single embryo-transfer and strict selection criteria and
judicious use of this advanced technology are advocated
to minimize maternal morbidity and mortality.
Microdissection testicular sperm extractions (Micro-
TESE) in azoospermic Klinfelter syndrome patients have
resulted not only in successful retrieval of spermatozoa for
intracytoplasmic sperm injection (ICSI) but also in normal
fertilization and clinical pregnancies. Swyer’s syndrome
patients are reared as females and have female external
and internal genitalia. However, with complete gonadal
failure they need Oocyte donation with ICSI/IVFET for
fertility. Those with partial androgen resistance (PAIS) due
to genetic mutation of androgen receptor have a spectrum
of abnormality like hypospadias, micropenis, undescended
testes and male infertility. Though 46xy PAIS males have
possibility of fatherhood complete AIS patients are female
phenotype and are raised as females. This category of
patients are encouraged and known to resort to fertiliza-
tion of donated oocyte using husband’s sperms. Resultant
embryos are transferred into surrogate uterus.
Advances in reproductive medicine in general and those
in assisted reproductive technology in particular have
revolutionized diagnosis of disorders of sex development
and the management of the associated infertility. These
advances have certainly provided fertility potentiation but
require judicious application coupled with expert genetic
counseling.
Published: 21 January 2014
doi:10.1186/1755-8166-7-S1-I20
Cite this article as: Vaidya and Gogte: Fertility options and challenges
for patients with cytogenetic infertility & disorders of sex development.
Molecular Cytogenetics 2014 7(Suppl 1):I20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit* Correspondence: vaidya.rama@gmail.com
Milan Polyclinic, 71-B Sarashwati Road, Santacruz (W), Mumbai, India
Vaidya and Gogte Molecular Cytogenetics 2014, 7(Suppl 1):I20
http://www.molecularcytogenetics.org/content/7/S1/I20
© 2014 Vaidya and Gogte; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
